CytoSite Bio
Business Services · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
14 Peterson Cir, Sudbury, Massachusetts,...Phone Number
(978) 460-0695Website
www.cytositebio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About CytoSite Bio
CytoSite Bio is pioneering advancements in immunotherapy by utilizing granzyme B to enhance cancer and autoimmune disease treatments. Their innovative platform includes a radiodiagnostic PET imaging solution that provides real-time insights into drug effectiveness and a preclinical radioimmunotherapy that has demonstrated a 100% response rate in animal models. Targeting researchers and healthcare professionals, CytoSite Bio aims to revolutionize clinical trial assessments and improve patient outcomes through their cutting-edge technologies. The company is focused on developing investigational products CSB-321 and CSB-421, which are not yet approved by regulatory authorities.Explore more
Popular SearchesCytoSite BioCytosite Biopharma IncCytosite BiopharmaSIC Code 87,873NAICS Code 54,541Show moreCytoSite Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CytoSite Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if CytoSite Bio has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at CytoSite Bio
Funding: Get notified immidiatlly once CytoSite Bio has new funding data
CytoSite Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on CytoSite Bio recently announced quarterly report
Check out if CytoSite Bio is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when CytoSite Bio launches new products
Click to see if CytoSite Bio had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to CytoSite Bio
Compare insights from companies similar to CytoSite Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$7.7M
11-50
Public
$340.5M
2015
KB
Kristi BalacyHead Senior Director, Clinical Development Operations & of Clinical Operations
Company Profile Activity
Activity Insights
CytoSite Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
CytoSite Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about CytoSite Bio.
CytoSite Bio Tech Stack
A closer look at the technologies used by CytoSite Bio
CytoSite Bio News & Media
CytoSite Bio Presents First-in-Human Data at Radiological Society of North American Annual Meeting
SUDBURY, Mass.--(BUSINESS WIRE)--CytoSite Bio, a company developing precision imaging products that determine patient response to immuno-oncology therapy today shared new data at the Radiological Society of North American (RSNA) Annual Meeting in Chicago, IL. In an oral presentation titled “Interim analysis of a first-in-human first-in-class phase I study of Granzyme B PET imaging for assessing single agent immune checkpoint inhibition response in melanoma and non-small cell lung cancer,” data
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CytoSite Bio
Sign Up For FreeTo access detailed company insights
CytoSite Bio is pioneering advancements in immunotherapy by utilizing granzyme B to enhance cancer and autoimmune disease treatments. Their innovative platform includes a radiodiagnostic PET imaging solution that provides real-time insights into drug effectiveness and a preclinical radioimmunotherapy that has demonstrated a 100% response rate in an... Read More
